Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared a post on LinkedIn:
“Kicking off Day 1 of the EORTC – European Organisation for Research and Treatment of Cancer Quality of Life Group meeting with a stunning sunrise!
Looking forward to insightful discussions and updates from all teams. Today, TOUR: Transforming cancer outcomes through Research will share progress on key projects, including:
- Immune Checkpoint Inhibitors – Louis Fox
- Common Data Models – Charlotte Moss
- Recruitment with Patient Organisations – Saran Green
- Bladder Cancer – Elke Rammant and Marieke van Leeuwen
- Prostate Cancer – Renée Bultijnck and Piet Ost
With some studies wrapping up Phase 1 & 2, others kicking off or preparing for Phase 3 and ethical approvals, there’s plenty of exciting progress ahead.
Stay tuned for more updates!”
